For research use only
| Cat No. | ABC-TC3948 |
| Product Type | Blood Products |
| Cell Type | Plasma |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Multiple Myeloma |
| Storage | Liquid Nitrogen |
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) provides clinically relevant samples for biomarker discovery and therapy studies.
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) is derived from the bone marrow of donors newly diagnosed with multiple myeloma and naive to systemic therapy. This plasma is cryopreserved immediately after collection. Functionally, this product exhibits in vitro activities associated with tumor-stromal interactions and angiogenesis, recapitulates key features of the myeloma bone marrow microenvironment, and displays elevated levels of pro-inflammatory cytokines (e.g., IL-6) and monoclonal proteins. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated), MM BM Plasma, Untreated Myeloma Bone Marrow Plasma, Newly Diagnosed MM BM Plasma |
| Species | Human |
| Cat.No | ABC-TC3948 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Plasma |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Multiple Myeloma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) serves as a physiologically relevant in vitro model for investigating the cellular and molecular mechanisms and disease-associated cellular processes of multiple myeloma. By analyzing its cytokine profiles, autoantibody content, and impact on bone marrow stromal cell interactions, researchers can deeply explore molecular mechanisms driving disease initiation, supporting discovery research and target identification related to multiple myeloma.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).